selected publications
-
academic article
- Safety and efficacy of convalescent plasma for severe COVID-19 2022-6-27
- The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies 2022-5-16
- Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths 2021-8-20